Save the date: March 31- April 4, 2011, Orlando, Florida (US)
Jeremy Bastid will attend the AACR 103rd annual meeting 2011
MARCH
Save the date: March 29-21, 2011, Amsterdam, Netherlands
Gilles Alberici and Jeremy Bastid will attend the Bio-europe spring 2011 meeting
- 2011 -
OCTOBER
Save the date: BIO-Europe 2011, October 31 - November 2, Dusseldorf, Germany
Gilles Alberici and Jeremy Bastid will attend Bio-Europe 2011 meeting
JUNE
Save the date: June 3, 2011, Saint Louis Hospital, Paris, France
Jeremy Bastid will attend the 3rd EuroMAbNet meeting (oral presentation)
APRIL
Save the date: April 2-6, 2011, Orlando, Florida (US)
Jeremy Bastid will attend the AACR 102nd annual meeting 2011
MARCH
Save the date: March 28-29, 2011, Lyon, France
Jeremy Bastid will attend the 6ème journées scientifiques du Cancéropôle CLARA
Save the date: March 14-16, 2011, Milan, Italy
Gilles Alberici and Jeremy Bastid will attend the Bio-europe spring 2011 meeting
- 2010 -
NOVEMBER
FIRST FINANCING ROUND, November 22, 2010
Orega Biotech closes its first financing round.
The new cancer therapy company will use proceeds to further advance its research programs
Lyon, France, November 22nd, 2010 – Orega Biotech, a new venture originally backed by Octalfa SAS and Inserm Transfert, which was set up in early 2010 to develop new cancer therapies, announces today that it has raised € 1 million of funding. New investors, SHAM, a Lyon-based insurance company specialized in medical malpractice liability insurance, Rhône-Alpes Création, a private Venture Capital Company (RSC) which invests in innovative start-ups based in the Rhone-Alpes region and Inserm Transfert Initiative, joined the historical investor Octalfa SAS, a French holding company managed by Gilles Alberici.
OCTOBER
Save the date : October 24-27, 2010, Madrid (Spain)
Jeremy Bastid will attend the NATURE - CNIO cancer symposium on "Frontiers in Tumour Progression"
